Abstract
Only a few nanoparticles (NPs) have passed FDA clinical trials for human use despite meaningful decades of in advances in NP drug-delivery systems and numerous published works. The proposal described here aims to understand the impact of protein presence on the ultimate location of nanoparticles inside mammalian cells. Silica particles containing fluorescent molecules such as Cy5, Alexa 6…